These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7519871)

  • 1. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma.
    Takeda O; Homma C; Maseki N; Sakurai M; Kanda N; Schwab M; Nakamura Y; Kaneko Y
    Genes Chromosomes Cancer; 1994 May; 10(1):30-9. PubMed ID: 7519871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
    Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
    Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
    Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
    Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T
    Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma.
    Caron H
    Med Pediatr Oncol; 1995 Apr; 24(4):215-21. PubMed ID: 7700165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome.
    Iolascon A; Lo Cunsolo C; Giordani L; Cusano R; Mazzocco K; Boumgartner M; Ghisellini P; Faienza MF; Boni L; De Bernardi B; Conte M; Romeo G; Tonini GP
    Cancer Lett; 1998 Aug; 130(1-2):83-92. PubMed ID: 9751260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
    Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
    Hogarty MD; Winter CL; Liu X; Guo C; White PS; Look AT; Brodeur GM; Maris JM
    Cancer Res; 2002 Nov; 62(22):6481-4. PubMed ID: 12438240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disomy 1 with terminal 1p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants.
    Kaneko Y; Kobayashi H; Maseki N; Nakagawara A; Sakurai M
    Int J Cancer; 1999 Jan; 80(1):54-9. PubMed ID: 9935230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.
    Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M
    Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.
    Mora J; Cheung NK; Kushner BH; LaQuaglia MP; Kramer K; Fazzari M; Heller G; Chen L; Gerald WL
    J Mol Diagn; 2000 Feb; 2(1):37-46. PubMed ID: 11272900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted.
    Caron H; Spieker N; Godfried M; Veenstra M; van Sluis P; de Kraker J; Voûte P; Versteeg R
    Genes Chromosomes Cancer; 2001 Feb; 30(2):168-74. PubMed ID: 11135433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
    Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
    Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma--clinical applications of molecular parameters.
    Brodeur GM
    Brain Pathol; 1990 Sep; 1(1):47-54. PubMed ID: 1669693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.
    Kaneko Y; Kanda N; Maseki N; Nakachi K; Takeda T; Okabe I; Sakurai M
    J Clin Oncol; 1990 Dec; 8(12):2005-13. PubMed ID: 2230892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of clinical heterogeneity in neuroblastoma.
    Brodeur GM; Nakagawara A
    Am J Pediatr Hematol Oncol; 1992 May; 14(2):111-6. PubMed ID: 1356315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma.
    Godfried MB; Veenstra M; Valent A; Sluis Pv; Voûte PA; Versteeg R; Caron HN
    Eur J Cancer; 2002 Jul; 38(11):1513-9. PubMed ID: 12110498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.